• / Free eNewsletters & Magazine
  • / My Account

CROs

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Research and Markets: Single Use Bioreactor Market by Product Type, Cell Type, Technology, End User - Global Forecast to 2019

    Research and Markets: Single Use Bioreactor Market by Product Type, Cell Type, Technology, End User - Global Forecast to 2019

  2. Mast Therapeutics Announces Management Change

    Mast Therapeutics Announces Management Change

  3. BioPharma Services is Pleased to Announce Dr. Janice Faulknor as Their New Dedicated Medical Director

    BioPharma Services is Pleased to Announce Dr. Janice Faulknor as Their New Dedicated Medical Director

  4. Late-Stage Businesses Drive Narrow Moats for CROs

    The top contract research organizations have opportunities to gain share in a rapidly growing industry.

  5. Research and Markets: CRO Quality Benchmarking - Phase IV Service Providers (6th edition)

    Research and Markets: CRO Quality Benchmarking - Phase IV Service Providers (6th edition)

  6. Research and Markets: China: Clinical Development Profile Report

    Research and Markets: China: Clinical Development Profile Report

  7. Mast Therapeutics Provides Update On Epic Study Enrollment And 2015 Milestones

    Mast Therapeutics Provides Update On Epic Study Enrollment And 2015 Milestones

  8. Research and Markets: Global CRO Market 2015-2019 with Covance, Parexel International, PRA Health Sciences & Quintiles Translational Dominating

    Research and Markets: Global CRO Market 2015-2019 with Covance, Parexel International, PRA Health Sciences & Quintiles Translational Dominating

  9. Health Care’s Outlook Clarifies

    Obamacare will benefit some sectors more than others, but poor economy and pricing pressures are the biggest challenges most health-care firms must face.

  10. Amid Turmoil, Don’t Discount Foreign Equities

    Use this screen to find overlooked small- and mid-cap international stocks.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.